Novartis India gets nod for Rs 231.15 crore buyback plan

26 Sep 2017 Evaluate

Novartis India has received an approval for buyback of up to 34.5 lakh shares, accounting for about 12.26% of the existing paid up capital of the company, for up to Rs 231.15 crore. The company’s board has approved a buyback proposal for purchase by the company of up to 34.5 lakh equity shares of Rs 5 each at a price of Rs 670 per share.

Novartis is a world leader in the research and development of products to protect and improve health and well-being. The company has core businesses in pharmaceuticals, vaccines, consumer health, generics, eye care and animal health.


Novartis Share Price

777.00 -3.55 (-0.45%)
21-Jan-2026 09:27 View Price Chart
Peers
Company Name CMP
Redington 265.25
Adani Enterprises 2066.25
Amrapali Industries 14.80
Rashi Peripheral 344.95
PDS 319.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×